Recent Annual Reports

Browse the latest SEC filings with AI-powered analysis. Get insights into corporate performance, financial trends, and business developments.

📊 1161 Reports

🤖 AI Analyzed

Recent

📄 Page 37 of 97

VARONIS SYSTEMS INC

10-K February 4, 2026

Key Highlights

Achieved solid operational performance in FY2024 with 12% revenue growth, driven...
Subscription revenue is a primary growth engine, comprising over 85% of total re...
Successfully transitioning customers to its SaaS platform and expanding market t...

Read Analysis

🤖 AI Generated

Terreno Realty Corp

10-K February 4, 2026

Key Highlights

Strong 2024 financial performance with $385 million revenue, $230 million FFO ($...
High operational efficiency demonstrated by 98.2% occupancy rate and 12.0% renta...
Strategic portfolio optimization through $407.6 million in acquisitions and $209...

Read Analysis

🤖 AI Generated

Weatherford International plc

10-K February 4, 2026

Key Highlights

Weatherford achieved strong financial performance in 2025, reporting $5.2 billio...
The company substantially strengthened its financial health by reducing total lo...
Management projects a cautiously optimistic outlook for 2026, anticipating mid-t...

Read Analysis

🤖 AI Generated

CANADIAN NATIONAL RAILWAY CO

40-F February 4, 2026

Key Highlights

Strong financial performance in 2025 with Total Revenues up 7% to $18.5 billion ...
Significant operational efficiency improvements, including a 5% increase in Reve...
Robust Free Cash Flow generation of $3.5 billion, enabling substantial sharehold...

Read Analysis

🤖 AI Generated

ZK International Group Co., Ltd.

20-F February 4, 2026

Key Highlights

Primary operations in China involve designing, manufacturing, and installing hig...
Serves diverse infrastructure projects including water distribution, natural gas...
Shares are traded on the Nasdaq Capital Market under the ticker ZKIN.

Read Analysis

🤖 AI Generated

Reynolds Consumer Products Inc.

10-K February 4, 2026

Key Highlights

Strong financial performance in 2025 with net revenues of $3.85 billion (up 4.2%...
Successful product innovation and market share gains, notably in Hefty® Brands a...
Achieved $50 million in cost savings through operational efficiencies and streng...

Read Analysis

🤖 AI Generated

GE HealthCare Technologies Inc.

10-K February 4, 2026

Key Highlights

Global leader in medical technology with solid performance, including total reve...
Strategic acquisitions, including MIM Software (completed early 2024) and planne...
Strategic focus on precision health, with heavy investment in AI, digital transf...

Read Analysis

🤖 AI Generated

Lakeshore Acquisition III Corp.

10-K February 4, 2026

Key Highlights

Experienced management team led by CEO/CFO Bill Chen with a strong track record ...
Successfully completed its IPO in May 2025, raising $69 million, with $70.8 mill...
Net Asset Value (NAV) of approximately $10.26 per public share as of December 31...

Read Analysis

🤖 AI Generated

ADVANCED MICRO DEVICES INC

10-K February 4, 2026

Key Highlights

Leadership in high-performance computing, graphics, and adaptive computing, with...
Strong growth in Datacenter (7% YoY) and Embedded (20% YoY) segments, driven by ...
Robust financial health with $5.5 billion in cash and $1.5 billion in short-term...

Read Analysis

🤖 AI Generated

NOVO NORDISK A S

20-F February 4, 2026

Key Highlights

Novo Nordisk delivered an exceptional year with robust growth, driven by innovat...
Net sales increased by 29% (CER) to DKK 232.3 billion, with operating profit up ...
Key product sales surged: Ozempic sales grew 52% (CER) to DKK 95.7 billion, Wego...

Read Analysis

🤖 AI Generated

PULTEGROUP INC/MI/

10-K February 4, 2026

Key Highlights

Strong financial performance in FY2025 with $15.7 billion revenue, $2.1 billion ...
Robust operational results including 28,500 home deliveries (up 5% YOY) and 29,8...
Solid financial health with $2.8 billion cash, a 25% net debt-to-capital ratio, ...

Read Analysis

🤖 AI Generated

REGENERON PHARMACEUTICALS, INC.

10-K February 4, 2026

Key Highlights

Robust R&D engine leading to two new drug approvals and three Phase 3 advancemen...
Strong financial position with $9.000 billion in cash and $6.800 billion in oper...
Successful new product launches and growth, including Eylea HD reaching $6.000 b...

Read Analysis

🤖 AI Generated

Stay Informed with AI Analysis

Get comprehensive insights from annual reports with our AI-powered analysis. Track corporate performance, financial trends, and strategic developments.

Back to Homepage